|52 Week Rng||-|
|P/E Ratio (TTM)||-|
|P/E Ratio (Fwd)||-|
|Div & Yield||-|
Medical Devices industry, long position. Insulet Corporation is expected to have good growth in the industry by its last 3 years, 1 year and 3 months success. At the same time adjusting our portfolio for 2,0 leverage.
A firm working on a diabetes treatment, a growing market due to number of patients globally, makes it a great stock to my portfolio together with Dexcom stock.